TLDR:
- Unlearn.AI, an AI company focused on disrupting the clinical trials process, has quadrupled its office space in San Francisco after raising $50 million in funding.
- The company signed a new lease for a four-year term at 303 Second St., occupying the fourth tower on the north side of the blocklong campus.
- Unlearn.AI plans to use the additional space to ramp up hiring and commercialize its product, which creates digital copies of clinical trial participants to shorten the drug-development process.
Unlearn.AI, an emerging artificial intelligence company, has secured a new lease for office space in San Francisco’s Financial District after raising $50 million in funding. The company will occupy the fourth tower at 303 Second St., quadrupling its office space to 17,220 square feet. The larger space will allow Unlearn.AI to expand its team and accelerate the commercialization of its product, which involves creating digital copies of clinical trial participants to streamline the drug-development process. Unlearn.AI plans to hire around 35 more employees this year.